HCC‐specific antigens such as PD‐1, PD‐L1, CTLA‐4, CD147 and endoglin (CD105) are potential targets for radionuclide antibody conjugates20, 21, 22, 23 (Table S2). The gene discussed is CTLA4; the disease is hepatocellular carcinoma.